Viraxclear & Viraxcare Revenue was Virax Biolabs’s largest revenue line in fiscal 2021, bringing in $104.82K of $123.82K (85%).
| Products and services [axis] | FY 2021 |
|---|---|
| Viraxclear & Viraxcare Revenue | $104.82K |
| Consulting Revenues | $19.00K |
| Total | $123.82K |
Virax Biolabs brought in $123.82K from its two revenue lines in fiscal 2021, the year ended March 31, 2021. Viraxclear & Viraxcare Revenue was the largest at $104.82K (84.7%), ahead of Consulting Revenues at $19.00K (15.3%).
Virax Biolabs (VRAX) reports its revenue by products and services [axis]. In fiscal 2021, Viraxclear & Viraxcare Revenue was its largest revenue line, bringing in $104.82K (84.7% of the total), followed by Consulting Revenues at $19.00K (15.3%).
Viraxclear & Viraxcare Revenue was Virax Biolabs' largest revenue line in fiscal 2021, bringing in $104.82K, or 84.7% of the $123.82K total across its two revenue lines.
Every figure comes from Virax Biolabs' annual financial filings, as reported. Each line keeps the name Virax Biolabs gives it, and years follow its fiscal calendar.
Virax Biolabs' revenue by products and services [axis] goes back to fiscal 2021, with figures through fiscal 2021. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.